Summary
Tissue factor (TF) is the primary cell-bound initiator of the coagulation protease cascade. The cytological distribution of TF in various tissues may be described on the basis of immunohistochemistry with epitope-defined monoclonal antibodies and the extravascular distribution of TF apparently represents a haemostatic envelope ready to activate coagulation when vascular integrity is disrupted. The present study localized TF in human breast cancer tissues when compared with normal breast gland tissues and benign disorders of the mammary gland. By use of a cocktail of three epitopedefined monoclonal antibodies, TF was detected only in the myoepithelia of the resting breast gland. In proliferating disorders like fibrocystic disease or in fibroadenomas, both myoepithelia and luminal epithelia showed TF expression. Of 115 breast cancers 93 reacted with anti-TF, in an inhomogeneous manner in terms of intensity and number of positive cells. There was a tendency for more positive and intensely stained cells to be found in well-differentiated structures such as tubules. Invasive ductal carcinomas exhibiting more positive and more strongly stained cells were less commonly metastatic to lymph nodes when compared with the tumours with no detectable or very low TF immunostaining. A semiquantitatively recorded score of TF immunostaining correlated with the procoagulatory activity measured (7 fibroadenomas and 24 carcinomas). The results of this study suggest that proliferation and differentiation of the mammary gland is associated with enhanced TF expression in the epithelia which are negative for TF staining in the resting gland. Malignant growth is characterized by randomly expressed epithelial TF, which expression is enhanced and more frequent in well-differentiated tumour cells.
Similar content being viewed by others
References
Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MA (1984) Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 160:618–623
Bloom HJC, Richardson WW (1957) Histological grading and prognosis in breast cancer. Br J Cancer 2:359–377
Bonnard C, Papermaster DS, Kraehenbuhl JP (1984) The streptavidin-biotin bridge technique: application in light and electron microscope immunohistochemistry. In: Polak JM, Varndell JM (eds) Immunolabelling for electron microscopy. Elsevier, Amsterdam, pp 95–111
Campbell AM (1987) Monoclonal antibody technology. Laboratory techniques in biochemistry and molecular biology, vol 13. Elsevier, Amsterdam
Drake TA, Morrissey JM, Edgington TS (1989) Selective cellular expression of tissue factor in human tissues: implications for disorders of hemostasis and thrombosis. Am J Pathol 134:1087–1098
Edgington TS, Mackman N, Brand K, Ruf W (1991) The structural biology of expression and function of tissue factor. Thromb Haemost 66:67–79134
Edwards RL, Rickles FR, Bobrove AM (1979) Mononuclear cell tissue factor: cell of origin and requirements for activation. Blood 54:359–370
Fleck RA, Rao LVM, Rapaport SI, Varki N (1990) Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res 59:421–437
Gregory SA, Edgington TS (1985) Tissue factor induction in human monocytes: two distinct mechanisms displayed by different alloantigen responsive T cell clones. J Clin Invest 76:2440–2445
Hartzell S, Ryder K, Lanahan A, Lau LF, Nathans D (1989) A growth factor-responsive gene of murine balb/c 3T3 cells encodes a protein homologous to human tissue factor. Mol Cell Biol 9:2567–2573
Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase technique: a comparison between ABC and an unlabeled antibody (PAP) procedure. J Histochem Cytochem 29:577–580
Hu T, Bach R, Konigsberg WH, Ezekowitz MD, Horton R, Todd M (1990) Tissue factor expression in human cancer cell lines. Proc Am Assoc Cancer Res 31:20
Levy GA, Leibowitz JL, Edgington TS (1981) Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease suspectibility in mice. J Exp Med 151:1150–1163
Morrissey JM, Fair DS, Edgington TS (1988) Monoclonal antibody analysis of purified and cell-associated tissue factor. Thromb Res 52:247–261
Nawroth PP, Stern DM (1986) Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 163:740–745
Nemerson Y (1988) Tissue factor and hemostasis. Blood 71:1–8
Nemerson Y, Bach R (1982) Tissue factor revisited. Prog Hemost Thromb 6:237–261
Novell PC (1986) Mechanism of tumor progression. Cancer Res 46:2203–2207
Rao LVM, Rapaport SI (1987) Affinity purification of human brain tissue factor utilizing factor VII bound to immobilized anti-factor VII. Anal Biochem 165:365–370
Sobin LH (1981) Histological typing of breast tumours. International histological classification of tumours. World Health Organization, Geneva
Weiss HJ, Lages B (1988) Evidence for tissue factor-dependent activation of classic extrinsic coagulation mechanism in blood obtained from bleeding tissue wounds. Blood 71:629–635
Wilcox JN, Smith KM, Schwartz SM, Gordon D (1989) Localization of tissue factor in normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 86:2839–2843
Zotter S, Lossnitzer A, Kunze K-D, Müller M, Hilkens J, Hilgers J, Hagemann P (1985) Epithelial markers for paraffin-embedded human tissues. Virchows Arch [A] 406:237–251
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sturm, U., Luther, T., Albrecht, S. et al. Immunohistological detection of tissue factor in normal and abnormal human mammary glands using monoclonal antibodies. Vichows Archiv A Pathol Anat 421, 79–86 (1992). https://doi.org/10.1007/BF01607039
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01607039